Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 554 of 6351
-
Can a targeted drug be safely used in children with rare tumors?
Disease control Recruiting nowThis study will collect safety information during routine medical care for children and adolescents in Japan who have been diagnosed with NTRK fusion-positive advanced or recurrent solid tumors who start treatment with repotrectinib. The study will describe how often side effects…
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a digestive enzyme help premature babies tolerate milk?
Symptom relief CompletedThe purpose of this study is to evaluate whether adding lactase enzyme to milk feeds can improve feeding tolerance in preterm neonates. Preterm infants may have immature gastrointestinal function and reduced intestinal lactase activity, which may contribute to difficulty digestin…
Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New drug cocktail aims to beat tough lymphoma
Disease control Recruiting nowDiffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma. Currently, the first-line treatment regimen based on R-CHOP can only achieve clinical cure for 50% to 60% of patients. Previous studies have shown that patients with high-risk factors have a …
Phase 2 • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for Alzheimer's? phase 3 trial of DMB-I begins
Disease control Recruiting nowThe goal of this clinical study is to learn if the study drug DMB-I (INN: Latrepirdine) works to treat Alzheimer type dementia in adults. It will also learn about the safety of DMB-I (INN: Latrepirdine). The main questions it aims to answer are: * Does DMB-I improve cognitive f…
Phase 3 • Sponsor: Bigespas LTD • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug cocktail targets Hard-to-Treat bladder cancer
Disease control Recruiting nowThis is a multicenter, open-label, Phase II clinical trial to evaluate the efficacy and safety of Trastuzumab Rezetecan (SHR-A1811) or in combination with Adebrelimab (SHR-1316) for HER2-expressing locally advanced or metastatic urothelial carcinoma (la/mUC).
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can early brain training and family coaching boost stroke recovery?
Disease control OngoingCognitive impairment and reduced quality of life are frequent consequences of ischemic stroke and can also affect family caregivers, who often assume caregiving responsibilities with limited preparation. Evidence regarding rehabilitation interventions initiated during the early p…
Sponsor: Althaia Xarxa Assistencial Universitària de Manresa • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New pill targets genetic form of polycystic kidney disease
Disease control OngoingThe purpose of the study is to evaluate the effect of VX-407 on height-adjusted total kidney volume (htTKV), safety, tolerability, and pharmacokinetics (PK) of VX-407.
Phase 2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Brain implant that learns: new hope for Parkinson's?
Disease control Recruiting nowThe purpose of the study is to evaluate the effectiveness of the Medtronic Adaptive DBS therapy (aDBS) for Parkinson's Disease in China with the Percept family of Implantable Neurostimulators (Percept PC and Percept RC).
Sponsor: MedtronicNeuro • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug trial aims to help kids with heart failure
Disease control Recruiting nowResearchers are looking for a better way to treat children who have heart failure with left ventricular systolic dysfunction (LVSD). Heart failure is a serious condition where the heart is unable to pump enough blood to meet the body's needs. This can lead to symptoms like shortn…
Phase 3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug TAK-188 aims to unleash immune system against Hard-to-Treat tumors
Disease control Recruiting nowTAK-188 is a new medicine that targets a protein called CCR8, which is found on the surface of certain cells (Tregs) inside tumors. These cells can weaken the body's ability to fight cancer. TAK-188 may help to remove these Tregs. Removing these Tregs may allow more cancer-fighti…
Phase 1/2 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New Camera-Guided surgery may cut recurrence of brain blood clots
Disease control Recruiting nowChronic subdural hematoma (CSDH) is a frequent condition in neurosurgery, leading to fluid accumulation between the meninges, brain compression, neurological dysfunction, and potentially herniation. The efficacy of treatments and their long-term outcomes remain uncertain, with no…
Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New pacemaker strategy could cut heart failure deaths after valve surgery
Disease control Recruiting nowIn this prospective, randomized, multicenter, open-label interventional clinical trial, the investigators' aim to test the effect of Cardiac Resynchronization Therapy (CRT) in cases of new-onset and persistent Left Bundle Branch Block (LBBB) occurring in the context of Transcathe…
Sponsor: Semmelweis University Heart and Vascular Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Frozen testicle tissue may help cancer survivors become dads
Disease control Recruiting nowThis is a pilot clinical trial to evaluate the feasibility and outcome of autologous transplantation of immature testicular tissue cryopreserved during childhood as a method of fertility preservation for prepubertal boys in case of gonadotoxic therapies. Freezing of immature tes…
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug shows promise in shrinking head and neck tumors before surgery
Disease control Recruiting nowThis phase II trial tests how well ivonescimab before surgery works in treating patients with stage II-IV head and neck cancer that can be removed by surgery (resectable). Ivonescimab is a bispecific monoclonal antibody that may interfere with the ability of tumor cells to grow a…
Phase 2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Gene therapy takes aim at Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis is a Phase 1/2, first-in-human, open-label, dose-escalating and expansion trial designed to assess the safety and efficacy of VNX-202 in patients with HER2 positive cancers.
Phase 1/2 • Sponsor: Vironexis Biotherapeutics Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New hope for elderly myeloma patients: talquetamab trial opens
Disease control Recruiting nowInduction therapy approaches in recent years have evolved, now utilizing triple or quadruple drug regimens in the majority of patients. By combining anti-CD38 antibodies, proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), and steroids, patients achieve longer remissions…
Phase 2 • Sponsor: Larysa Sanchez • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Triple threat: new Pre-Surgery combo targets stomach cancer
Disease control Recruiting nowThe purpose of this study is to investigate the safety and efficacy of HFRT plus neoadjuvant ICT in locally advanced resectable GEJA.
Phase 1/2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for advanced colon cancer: experimental drug combo enters phase 3 trial
Disease control Recruiting nowA Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with mFOLFOX6 (Oxaliplatin, Leucovorin and 5-Fluorouracil) versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer(H…
Phase 3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New heart device aims to cut hospital stays and deaths in heart failure patients
Disease control Recruiting nowThe purpose of this prospective, multi-center, propensity-matched coverage with evidence development (CED) study is to assess the impact of cardiac contractility modulation (CCM) on mortality and heart failure hospitalizations in Medicare-eligible patients with heart failure who …
Sponsor: Impulse Dynamics • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New cocktail aims to shrink tough colorectal tumors
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of two dose levels of ONO-4578 with Opdivo® when added to mFOLFOX6 and bevacizumab versus SOC as first-line treatment for advanced CRC.
Phase 2 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC